Search

You searched for "Research"

2249 results found

Planes, trams, and auditoriums: Beware predatory conferencing

4 December 2024 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Predatory open-access journals and predatory conferences are considered the two main areas of predatory infiltration in academic medicine that are of growing concern [1–7]. Unsolicited publishing requests from potentially predatory publishers occur frequently among faculty in ophthalmology [8]. Predatory conferencing...

Inherited retinal disorders now the leading cause of blindness

1 April 2014 | | EYE - Vitreo-Retinal
The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...

AI predicts eye damage from autoimmune drug, years before symptoms appear

1 September 2025 | artificial intelligence, hydroxychloroquine, pharmacology, research, Moorfields
A novel AI tool could transform screening for patients taking hydroxychloroquine by spotting early signs of eye damage, according to a study published in Opthalmology Retina. Researchers have devised an artificial intelligence (AI) system that can detect and predict serious...

Redefining the future of sight - Moorfields Eye Charity launches first major national funding initiative

29 July 2026 | research, treatment, charity
New grants strategy aims to enable innovation at scale and transform eye health. Moorfields Eye Charity has launched a significant national funding initiative to accelerate the urgent development of new eye health treatments and interventions. The new Discovery and Translation...

Moorfields Eye Charity appoints Dr Louise Wood CBE as new chair

3 June 2024 | Louise Wood, Moorfields, Industry, infrastructure, charity, hospital, grants, Appointments
Dr Louise Wood CBE has been appointed as Moorfields Eye Charity’s new chair and will succeed Mervyn Walker when he steps down from the role in July 2024.

GREG: An Introduction to Diabetic Retinopathy Grading

4 June 2026 -5 June 2026
Gloucestershire Research & Education Group An Introduction to Diabetic Retinopathy (DR) Grading

Esme’s Umbrella announces the world’s first Charles Bonnet Syndrome Essay Prizes

20 February 2023 |
Esme’s Umbrella (www.charlesbonnetsyndrome) has just announced the world’s first Charles Bonnet Syndrome Essay Prizes.

Beyond vision loss: Why doctors should know about Charles Bonnet Syndrome

19 January 2026 | | EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
Over 250 years have passed since Charles Bonnet’s seminal essay, in which he described the symptoms of the syndrome that now takes his name [1]. Charles Bonnet Syndrome (CBS) describes the occurrence of visual hallucinations in people with significant visual...

EQUALeyes: Illuminating insights into using health data, AI and inclusion

24 October 2024
Reflecting the Bloomsbury Festival theme of Human.Kind, and current public conversations on the benefits and potential threats of AI, we bring together leaders in the field of healthcare AI to discuss key issues, with a special focus on eyes.

First medical AI model with globally representative data

22 September 2025 | NHS, Medical AI, Eye Images, Retina, UCL, ophthalmology
Quest to build the first medical AI foundation model with globally representative data. A research consortium of over 100 study groups in more than 65 countries has launched the Global RETFound initiative, a collaborative effort to develop the first globally...

My Top Five: Tips for a successful grant application in ophthalmology

3 February 2026 | | EYE - General
Securing funding for an educational or research initiative in ophthalmology can often feel like a competitive, confusing and time-intensive task. Whether you’re an early-career researcher looking to get your first project off the ground or an experienced educator aiming to...

First treatment for late-stage dry AMD rejected by UK drug regulator

17 February 2025 | AMD, geographic atrophy, Dry, macular society, Apellis, pharma
Leading sight loss charity the Macular Society has responded to the decision not to approve the first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration. The decision is a significant setback for those affected by...